Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

IMNM
Immunome, Inc.
stock NASDAQ

At Close
Aug 11, 2026 3:25:34 PM EDT
26.31USD+2.413%(+0.62)875,267
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-25.69)0
After-hours
Aug 11, 2026 4:55:30 PM EDT
26.46USD+0.570%(+0.15)2,617
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 11, 2022
08:36AM EST  The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In   Benzinga
Jan 10, 2022
04:28PM EST  Immunome Reports Received FDA Clinical Hold Letter Related To Its Recently-Submitted Investigational New Drug Application Requesting Further Info; Co. Has Initiated Requisite Work   Benzinga
04:15PM EST  Immunome Provides Update on Investigational New Drug Application for IMM-BCP-01 for the Treatment of COVID-19   Business Wire
Dec 7, 2021
07:00AM EST  Immunome to Participate in Fireside Chat Hosted by Cantor Fitzgerald   Business Wire
Dec 1, 2021
08:41AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case   Benzinga
08:36AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment, Regulatory Setbacks For CTI Biopharma, Favorable Ruling For BioXcel, Viatris In Tecfidera Patent Case   Benzinga
07:40AM EST  Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529).   RTTNews
07:14AM EST  Immunome Says Expects IMM-BCP-01 Antibody Cocktail To Neutralize SARS-CoV-2 Omicron Variant   Benzinga
07:13AM EST  Immunome Expects IMM-BCP-01 Antibody Cocktail To Neutralize Omicron Variant; Stock Surges   RTTNews
07:00AM EST  Immunome Expects IMM-BCP-01 Antibody Cocktail To Neutralize the SARS-CoV-2 Omicron Variant   Business Wire
Nov 30, 2021
04:11PM EST  Why Are Immunome Shares Trading Higher Today?   Benzinga
Nov 29, 2021
07:12AM EST  Immunome Says Submits IND Application For IMM-BCP-01 For Treatment Of COVID-19   RTTNews
07:03AM EST  Immunome Announces Submission Of An Investigational New Drug Application For IMM-BCP-01 For The Treatment Of COVID-19   Benzinga
07:00AM EST  Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19   Business Wire
Nov 15, 2021
05:00PM EST  Immunome Reports Third Quarter 2021 Financial Results   Business Wire
Nov 9, 2021
04:06PM EST  Immunome to Present at the Stifel Healthcare Conference   Business Wire
Oct 29, 2021
10:05AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021   Benzinga
08:33AM EDT  Cantor Fitzgerald Initiates Coverage On Immunome with Overweight Rating, Announces Price Target of $35   Benzinga
Oct 20, 2021
08:02AM EDT  Immunome Announces Submission For Publication Of Pre-Clinical Research Detailing Importance Of Antibody Cocktail For SARS-CoV-2 Treatment And Prophylaxis   Benzinga
Oct 7, 2021
09:00AM EDT  Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics   Business Wire
Sep 30, 2021
04:36PM EDT  Immunome To Present Preclinical Data On Anti IL-38 Antibody Program At The American Association For Cancer Research NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics   Benzinga
Sep 22, 2021
04:22PM EDT  Immunome To Present At Cantor Healthcare Conference Wednesday, Sept. 29 At 8:40 a.m. EDT   Benzinga
04:07PM EDT  Immunome to Present at the Cantor Global Healthcare Conference   Business Wire
Sep 15, 2021
04:05PM EDT  Immunome to Present At Oppenheimer Fall Healthcare Life Sciences And MedTech Summit   Benzinga
Sep 7, 2021
07:27AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda And Delta Plus Variants In Pre-clinical Testing   RTTNews
07:15AM EDT  Immunome Says Its IMM-BCP-01 'Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing'   Benzinga
07:00AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes SARS-CoV-2 Lambda and Delta Plus Variants in Pre-clinical Testing   Business Wire
Aug 23, 2021
10:56AM EDT  Longboat Family Office Reports In 13G Filing A 5.59% Stake In Immunome   Benzinga
Aug 19, 2021
04:09PM EDT  Immunome Q2 EPS $(0.46) Misses $(0.39) Estimate   Benzinga
04:05PM EDT  Immunome Reports Second Quarter 2021 Financial Results   Business Wire
Jul 20, 2021
02:56PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher   Benzinga
12:10PM EDT  Mid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide   Benzinga
10:26AM EDT  Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results   Benzinga
08:21AM EDT  Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant   Benzinga
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
07:28AM EDT  Immunome Inc. (IMNM) said that its three-antibody cocktail (IMM-BCP-01) has neutralized the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing.   RTTNews
07:14AM EDT  Immunome Antibody Cocktail Neutralizes SARS-CoV-2 Delta Variant In Pre-clinical Testing; Stock Surges   RTTNews
07:05AM EDT  Immunome Antibody Cocktail Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing   Benzinga
07:03AM EDT  Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing   Business Wire
Jul 6, 2021
07:00AM EDT  Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference   Business Wire
Jun 30, 2021
07:00AM EDT  Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board   Business Wire
Jun 17, 2021
07:21AM EDT  Immunome Appoints Franklyn Prendergast To Board   RTTNews
07:00AM EDT  Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors   Business Wire
May 27, 2021
04:05PM EDT  Immunome to Present at the Jefferies Virtual Healthcare Conference   Business Wire
May 20, 2021
10:04AM EDT  Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail   Benzinga
07:55AM EDT  Immunome Announces $4.3 Mln Increase Awarded By DOD For Continued Development Of An Antibody Cocktail   RTTNews
07:06AM EDT  Immunome Announces Additional $4.3M Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern   Benzinga
07:00AM EDT  Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern   Business Wire
May 12, 2021
06:22AM EDT  Immunome Q1 Loss Per Share $0.37 Vs Loss Per Share $2.44 Last Year   RTTNews
06:08AM EDT  Immunome Q1 EPS $(0.37) Up From $(2.44) YoY   Benzinga
06:00AM EDT  Immunome Reports First Quarter 2021 Financial Results   Business Wire
Apr 26, 2021
11:05AM EDT  Immunome shares were trading higher after the company reported that its SARS-CoV-2 antibody cocktail neutralizes the UK, South Africa, Brazil, and California variants in its preclinical testing. Its currently progressing towards IND Filing.   Benzinga
08:37AM EDT  Immunome Raises $27M Via Private Equity Placement At 9%   Benzinga
08:09AM EDT  Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies   Benzinga
06:03AM EDT  Immunome Reports Co.'s SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing   Benzinga
06:00AM EDT  Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing   Business Wire
05:50AM EDT  Immunome Announces $27 Million Private Placement   Business Wire
Apr 20, 2021
08:14AM EDT  Immunome Appoints Corleen Roche As Chief Financial Officer   Benzinga
08:06AM EDT  Immunome Appoints Corleen Roche As CFO   RTTNews
08:00AM EDT  Immunome Appoints Corleen Roche as Chief Financial Officer   Business Wire
Mar 30, 2021
08:13AM EDT  Immunome Appoints Dennis Giesing To The Role Of Chief Development Officer   RTTNews
08:00AM EDT  Immunome Appoints Dr. Dennis Giesing as Chief Development Officer   Business Wire
Mar 25, 2021
05:16PM EDT  Immunome Q4 EPS $(0.40) vs $(2.66) In Same Qtr. Last Year   Benzinga
05:14PM EDT  Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update   Business Wire
Mar 23, 2021
07:24AM EDT  Immunome Announces Advancement Of Antibody Against IL-38 To IND-Enabling Studies; Sees IND Filing By 2H 2021   Benzinga
07:12AM EDT  Immunome Advances Proprietary Antibody Against IL-38 Into IND-enabling Studies And Expects Filing An IND In H2 2021   RTTNews
07:00AM EDT  Immunome Advances Its Proprietary Antibody Against IL-38, a Novel Innate Immune Checkpoint, into IND-enabling Studies   Business Wire
Feb 19, 2021
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
Feb 18, 2021
03:36PM EST  Mid-Afternoon Market Update: Crude Oil Down 1.8%; HighCape Capital Acquisition Shares Surge   Benzinga
12:19PM EST  Mid-Day Market Update: Silver Down 1%; Greenland Technologies Shares Spike Higher   Benzinga
10:17AM EST  Mid-Morning Market Update: Markets Open Lower; Walmart Reports Downbeat Earnings   Benzinga
09:52AM EST  Shares of Immunome, Inc. (IMNM) are up more than 125% Thursday morning after the company announced the discovery of antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant, in pseudovirus testing.   RTTNews
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
07:04AM EST  Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing   Benzinga
Feb 4, 2021
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
Feb 3, 2021
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
07:03AM EST  Abzena Selected by Immunome To Develop And Manufacture Antibody Cocktail For Immunome's COVID-19 Antibody Based Treatment   Benzinga
Feb 1, 2021
07:02AM EST  Immunome Says Research Reveals 'Broad Super Responder Memory B Cell Response' To COVID-19   Benzinga
07:00AM EST  Immunome's Research Reveals a Broad Super Responder Memory B Cell Response to the SARS-CoV-2 Virus   Business Wire
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 13, 2021
03:12PM EST  Immunome 13G Filing From Alpine Global Shows New 7.5% Stake In Co.   Benzinga
Dec 30, 2020
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 10, 2020
08:00AM EST  Immunome Provides Organizational Update: Appoints Richard Baron to its Board of Directors and Sandra Stoneman as Chief Legal Officer and Corporate Secretary   Business Wire
Dec 4, 2020
06:33AM EST  Immunome 8-K Shows CFO, Richard Fitzgerald, Resigned; Names Diane Marcou Interim CFO   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 18, 2020
09:39AM EST  Immunome shares were trading lower after the company reported Q3 EPS down from last year.   Benzinga
Nov 17, 2020
05:55PM EST  Immunome Q3 EPS $(7.52) Down From $(2.50) YoY   Benzinga
05:53PM EST  Immunome Reports Third Quarter 2020 Financial Results and Significant Progress   Business Wire
Oct 30, 2020
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
10:35AM EDT  Benzinga's Top Upgrades, Downgrades For October 27, 2020   Benzinga
06:16AM EDT  A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Earnings   Benzinga
05:00AM EDT  Chardan Capital Initiates Coverage On Immunome with Buy Rating, Announces Price Target of $18   Benzinga
Oct 13, 2020
04:05PM EDT  Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering   Business Wire
Oct 11, 2020
11:35AM EDT  Last Week's Notable Insider Buys: Element Solutions, Selecta Biosciences And More   Benzinga
Oct 2, 2020
11:37AM EDT  Immunome Shares Open For Trade At $15.66; IPO Priced At 12/Share   Benzinga
09:56AM EDT  Immunome Shares Expected To Open For Quote At 11:25 a.m. EDT, Expected To Open For Trade After 11:35 a.m. EDT; IPO Priced At 12/Share   Benzinga
05:41AM EDT  Immunome Priced Upsized 3.2M Share IPO @$12/Share   Benzinga
Oct 1, 2020
09:15PM EDT  Immunome Announces Pricing Of Upsized IPO Of 3.25 Mln Shares At $12/shr   RTTNews
08:23PM EDT  Immunome Announces Pricing of Upsized Initial Public Offering   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC